journal article·2023-01-29Open access

Stabilizing A Vascularized Autologous Matrix with Flexible Magnesium Scaffolds to Reconstruct Dysfunctional Left Ventricular Myocardium in a Large-Animal Feasibility Study

Tobias Schilling, Serghei Cebotari, Tim Kaufeld, Igor Tudorache, Gudrun Brandes, Dagmar Hartung, Frank Wacker, Michael Bauer, Axel Haverich, Thomas Hassel

Abstract

The surgical reconstruction of dysfunctional myocardium is necessary for patients with severe heart failure. Autologous biomaterials, such as vascularized patch materials, have a regenerative potential due to in vivo remodeling. However, additional temporary mechanical stabilization of the biomaterials is required to prevent aneurysms or rupture. Degradable magnesium scaffolds could prevent these life-threatening risks. A left ventricular transmural defect was reconstructed in minipigs with a piece of the autologous stomach. Geometrically adaptable and degradable scaffolds made of magnesium alloy LA63 were affixed on the epicardium to stabilize the stomach tissue. The degradation of the magnesium structures, their biocompatibility, physiological remodeling of the stomach, and the heart’s function were examined six months after the procedure via MRI (Magnetic Resonance Imaging), angiography, µ-CT, and light microscopy. All animals survived the surgery. Stable physiological integration of the stomach patch could be detected. No ruptures of the grafts occurred. The magnesium scaffolds showed good biocompatibility. Regenerative surgical approaches for treating severe heart failure are a promising therapeutic alternative to the currently available, far from optimal options. The temporary mechanical stabilization of viable, vascularized grafts facilitates their applicability in clinical scenarios.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Magnesium Alloys: Properties and Applications · Cardiac Structural Anomalies and Repair · Aluminum Alloys Composites Properties

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Cardiothoracic, Transplantation, and Vascular Surgery, Medical School Hannover, 30625 Hannover, Germany

Institut National de Chirurgie Cardiaque et de Cardiologie Interventionelle, 1210 Luxembourg, Luxembourg

Department of Cardiac Surgery, Universitätsspital Zürich, 8091 Zürich, Switzerland

Institute of Neuroanatomy and Cell Biology in the Center of Anatomy, Medical School Hannover, 30625 Hannover, Germany

Institute for Radiology, Hannover Medical School, 30625 Hannover, Germany

IAV GmbH, 38518 Gifhorn, Germany

Institut für Werkstoffkunde (Materials Science), Leibniz Universität Hannover, 30823 Garbsen, Germany

Funding

German Research Foundation (DFG)

References (38)

Show source-provided references
1. Left ventricular aneurysm: A new surgical approach10.1055/s-2007-1013899 ↗
2. Tissue engineering of vascularized myocardial prosthetic tissue. Biological and solid matrices10.1007/s00104-010-2032-1 ↗
3. Viable vascularized autologous patch for transmural myocardial reconstruction10.1016/j.ejcts.2009.02.038 ↗
4. Vascularization Strategies for Tissue Engineering10.1089/ten.teb.2009.0085 ↗
5. Left Ventricular Wall Reconstruction with Autologous Vascularized Gastric Graft in a Porcine Pilot Model
6. Myocardial reconstruction in ischaemic cardiomyopathy10.1093/ejcts/ezy367 ↗
7. Geometric adaption of biodegradable magnesium alloy scaffolds to stabilise biological myocardial grafts. Part I10.1007/s10856-013-5100-5 ↗
8. Biskup, C., Hepke, M., Grittner, N., Plorin, T., Hassel, T., Bormann, D., Schilling, T., Hilfiker, A., Cebotari, S., and Tudorache, I. (2009, January 18). AWIJ cutting of structures made of magnesium alloys for the cardiovascular surgery. Proceedings of the American WJTA Conference and Expo, Houston, TX, USA.
9. In vivo degradation of magnesium alloy LA63 scaffolds for temporary stabilization of biological myocardial grafts in a swine model10.1515/bmt-2012-0047 ↗
10. Weidling, M., Besdo, S., Schilling, T., Bauer, M., Hassel, T., Haverich, A., and Wriggers, P. (2013). Finite element simulation of myocardial stabilising structures and development of new designs. Biomed. Technol., 58.10.1515/bmt-2013-4061 ↗
11. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
12. Epidemiology of heart failure10.1002/ejhf.1858 ↗
13. Robertson, J., McElduff, P., Pearson, S.A., Henry, D.A., Inder, K.J., and Attia, J.R. (2012). The health services burden of heart failure: An analysis using linked population health data-sets. BMC Health Serv. Res., 12.10.1186/1472-6963-12-103 ↗
14. Bundesamt, S. (2023, January 10). Krankheitskostenrechnung: Krankheitskosten: Deutschland, Jahre, Krankheitsdiagnosen (ICD10). Available online: https://www-genesis.destatis.de/genesis.
15. Generation of bioartificial heart tissue by combining a three-dimensional gel-based cardiac construct with decellularized small intestinal submucosa
16. Right ventricular outflow tract repair with a cardiac biologic scaffold10.1159/000331400 ↗
17. Preparation of cardiac extracellular matrix from an intact porcine heart10.1089/ten.tec.2009.0392 ↗
18. Uterine myometrium as a cell patch as an alternative graft for transplantation to infarcted cardiac myocardium: A preliminary study10.1177/039139880803100109 ↗
19. Tissue engineering of heart valves: Biomechanical and morphological properties of decellularized heart valves
20. The use of extracellular matrix as an inductive scaffold for the partial replacement of functional myocardium10.3727/000000006783982368 ↗
21. Extracellular matrix scaffold for cardiac repair10.1161/CIRCULATIONAHA.104.525436 ↗
22. Extracellular matrix for myocardial repair10.1532/hsf.917 ↗
23. Biodegradable Magnesium Alloys: A Review of Material Development and Applications10.4028/www.scientific.net/JBBTE.12.25 ↗
24. Evaluation of short-term effects of rare earth and other elements used in magnesium alloys on primary cells and cell lines10.1016/j.actbio.2009.09.024 ↗
25. Buffer-regulated biocorrosion of pure magnesium10.1007/s10856-011-4517-y ↗
26. Corrosion of magnesium10.1179/imr.1993.38.3.138 ↗
27. Comparison between three in vitro methods to measure magnesium degradation and their suitability for predicting in vivo degradation10.1177/0391398818772777 ↗
28. Foreign body reaction to biomaterials10.1016/j.smim.2007.11.004 ↗
29. Exploiting the inflammatory response on biomaterials research and development10.1007/s10856-015-5423-5 ↗
30. Effect of frequency on fatigue crack growth behavior of magnesium alloy AZ61 under immersed 3.5mass% NaCl environment10.1016/j.msea.2010.12.048 ↗
31. Corrosion fatigue of biomedical metallic alloys: Mechanisms and mitigation10.1016/j.actbio.2011.09.012 ↗
32. Corrosion fatigue behaviors of two biomedical Mg alloys—AZ91D and WE43—In simulated body fluid10.1016/j.actbio.2010.07.026 ↗
33. Third body effects and material fluxes in tribocorrosion systems involving a sliding contact10.1016/S0043-1648(03)00561-1 ↗
34. Degradable biomaterials based on magnesium corrosion10.1016/j.cossms.2009.04.001 ↗
35. Biodegradable metals10.1016/j.mser.2014.01.001 ↗
36. Design of a pseudo-physiological test bench specific to the development of biodegradable metallic biomaterials10.1016/j.actbio.2007.09.012 ↗
37. Neuropathology of aluminum toxicity in rats (glutamate and GABA impairment)10.1016/S1043-6618(02)00336-5 ↗
38. Fast escape of hydrogen from gas cavities around corroding magnesium implants10.1016/j.actbio.2012.10.008 ↗